ARCHIVES

In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs

This article is from The Cancer Letter archive.

Vol. 21 No. 35 | September 15, 1995

Download PDF Visit The Full Archive

Related Articles

In Brief: Treatment Reorganization Will Give Rauscher “Lumps,” He Says; Coordinating Group Favored

August 16, 1974

Rush-Presbyterian Professor Committed Misconduct, ORI Says

October 6, 1995

Center Seeks HER-2 Positive Breast Cancer Patients

August 29, 2003

Bush Budget Stresses Research Now, Public Health Interventions Later.

April 13, 2001

Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer

April 30, 2004

FDA Proposes To Require Electronic Submission

May 3, 2002